These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 21468005)
41. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Melief CJ; Van Der Burg SH; Toes RE; Ossendorp F; Offringa R Immunol Rev; 2002 Oct; 188():177-82. PubMed ID: 12445291 [TBL] [Abstract][Full Text] [Related]
42. RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells. Tyagi RK; Mangal S; Garg N; Sharma PK Expert Rev Anticancer Ther; 2009 Jan; 9(1):97-114. PubMed ID: 19105710 [TBL] [Abstract][Full Text] [Related]
44. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. da Cunha A; Antoniazi Michelin M; Cândido Murta EF Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825 [TBL] [Abstract][Full Text] [Related]
45. Dendritic cell fusion vaccines for cancer immunotherapy. Rosenblatt J; Kufe D; Avigan D Expert Opin Biol Ther; 2005 May; 5(5):703-15. PubMed ID: 15934845 [TBL] [Abstract][Full Text] [Related]
46. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells]. Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759 [TBL] [Abstract][Full Text] [Related]
47. [Dendritic cells for cancer immunotherapy]. Kakimi K; Kondo A; Matsushita H Nihon Rinsho; 2012 Dec; 70(12):2130-5. PubMed ID: 23259385 [TBL] [Abstract][Full Text] [Related]
48. Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy. Alli RS; Khar A Indian J Biochem Biophys; 2002 Dec; 39(6):363-7. PubMed ID: 22905392 [TBL] [Abstract][Full Text] [Related]
49. Plasmacytoid Dendritic Cells and Cancer Immunotherapy. Fu C; Zhou L; Mi QS; Jiang A Cells; 2022 Jan; 11(2):. PubMed ID: 35053338 [TBL] [Abstract][Full Text] [Related]
50. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen. Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656 [TBL] [Abstract][Full Text] [Related]
51. A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival. Sharbi-Yunger A; Grees M; Cafri G; Bassan D; Eichmüller SB; Tzehoval E; Utikal J; Umansky V; Eisenbach L Int J Cancer; 2019 Feb; 144(4):909-921. PubMed ID: 30106470 [TBL] [Abstract][Full Text] [Related]
52. Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine. Hassannia H; Ghasemi Chaleshtari M; Atyabi F; Nosouhian M; Masjedi A; Hojjat-Farsangi M; Namdar A; Azizi G; Mohammadi H; Ghalamfarsa G; Sabz G; Hasanzadeh S; Yousefi M; Jadidi-Niaragh F Immunology; 2020 Jan; 159(1):75-87. PubMed ID: 31587253 [TBL] [Abstract][Full Text] [Related]